newsfilter
← Latest News
GlobeNewswire·

Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update

Clinical Development Strategy for Alzheimer’s Disease Remains the Focus as Anavex Advances Regulatory Progress Across All Three Programs Anavex Submits Completed Alzheimer’s Disease Clinical Study Data and Rett